Literature DB >> 2517705

Hormonal therapy in climacteric women: compliance and its socioeconomic impact.

M Notelovitz1.   

Abstract

Hormonal therapy can effectively enhance the quality of life for postmenopausal women, and prevent climacteric-related conditions such as osteoporosis. Since long-term therapy is often required, compliance becomes an important issue. This can best be achieved by measurement, documenting the reason for hormone therapy, and by repeated measurement, demonstrating a response to the treatment. Case histories documenting this principle are described.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2517705      PMCID: PMC1580370     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  12 in total

Review 1.  Menopausal hot flush.

Authors:  T Tulandi; S Lal
Journal:  Obstet Gynecol Surv       Date:  1985-09       Impact factor: 2.347

2.  Psychiatric morbidity and the menopause: survey of a gynaecological out-patient clinic.

Authors:  C B Ballinger
Journal:  Br J Psychiatry       Date:  1977-07       Impact factor: 9.319

3.  Post-menopausal osteoporosis. A practical approach to its prevention.

Authors:  M Notelovitz
Journal:  Acta Obstet Gynecol Scand Suppl       Date:  1986

Review 4.  The role of the gynecologist in osteoporosis prevention: a clinical approach.

Authors:  M Notelovitz
Journal:  Clin Obstet Gynecol       Date:  1987-12       Impact factor: 2.190

5.  Long-term estrogen replacement therapy prevents bone loss and fractures.

Authors:  B Ettinger; H K Genant; C E Cann
Journal:  Ann Intern Med       Date:  1985-03       Impact factor: 25.391

6.  Psychiatric morbidity and the menopause; screening of general population sample.

Authors:  C B Ballinger
Journal:  Br Med J       Date:  1975-08-09

7.  Oestrogen therapy and the menopausal syndrome.

Authors:  S Campbell; M Whitehead
Journal:  Clin Obstet Gynaecol       Date:  1977-04

8.  Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen.

Authors:  N S Weiss; C L Ure; J H Ballard; A R Williams; J R Daling
Journal:  N Engl J Med       Date:  1980-11-20       Impact factor: 91.245

9.  Efficacy of a continuous estrogen-progestin regimen in the menopausal patient.

Authors:  L Weinstein
Journal:  Obstet Gynecol       Date:  1987-06       Impact factor: 7.661

10.  Oral medroxyprogesterone in the treatment of postmenopausal symptoms.

Authors:  I Schiff; D Tulchinsky; D Cramer; K J Ryan
Journal:  JAMA       Date:  1980-09-26       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.